54
Growth Score in past quarter
pts
Heat Score 54 in past quarter
-18 pts
Company Performance Metrics
Score
Trend
AI Content may contain mistakes and is not legal, financial or investment advice.Learn more.
Growth Score - The measure of growth based on company activity, operational metrics, and investments
Growth Trend - The change in the growth score over the given time period
Heat Score - The measure of the market interest, media activity, and Crunchbase profile activity
Heat Trend - The change in the heat score over the given time period
Recent Milestones
Raised Funding Round
Jan 1, 1970
Lorem ipsum dolor sit amet, consectetur
Raised Funding Round
Jan 1, 1970
Lorem ipsum dolor sit amet, consectetur
Raised Funding Round
Jan 1, 1970
Lorem ipsum dolor sit amet, consectetur
See more interactive data and historical milestones on desktop for the best experience
1581102
Endurx Pharmaceuticals develops peptide-directed nanoparticle therapeutics for hard-to-treat cancers.
About the Company
Endurx Pharmaceuticals develops a novel drug delivery platform using peptide-directed polymeric nanoparticle therapeutics. The company focuses on creating solutions for hard-to-treat cancers and other diseases. Their actively-targeting macromolecule drug delivery system aims to improve the efficacy and safety of treatments for solid tumors and
selected other indications.